Original Article
Single-institutions experience with acute kidney injury in the brain injury population
AME Medical Journal
2018;
3:
59
.
(23 April 2018)
Original Article
Relationship among biomarkers of iron metabolism and severity of underlying nonalcoholic steatohepatitis (NASH)
AME Medical Journal
2018;
3:
58
.
(20 April 2018)
Editorial
Application and approval of cancer drugs in China: acceleration should be kept in progress
AME Medical Journal
2018;
3:
57
.
(20 April 2018)
Editorial
Increased specialization in spine surgery and its implications on delivery and access to care in the United States Healthcare System
AME Medical Journal
2018;
3:
56
.
(13 April 2018)
Editorial
Current evidence for active surveillance for intermediate risk prostate cancer: editorial on comparison of pathological and oncologic outcomes in "favorable risk" GS 3+4 and low risk GS6 prostate cancer by Gearman et al., Journal of Urology
AME Medical Journal
2018;
3:
55
.
(04 April 2018)
Editorial
Abiraterone survival benefit is independent of pain, prostate-specific antigen and Gleason sum in men with chemo-naïve metastatic castration-resistant prostate cancer (analysis of COU-AA-302)
AME Medical Journal
2018;
3:
54
.
(04 April 2018)
Editorial
Fructosamine: a promising new risk stratification tool?
AME Medical Journal
2018;
3:
53
.
(04 April 2018)
Editorial
A nucleotide-binding oligomerization domain for innate immunity and reproduction
AME Medical Journal
2018;
3:
52
.
(03 April 2018)
Original Article
Metabolic inflammatory syndrome: a novel concept of holistic integrative medicine for management of metabolic diseases
AME Medical Journal
2018;
3:
51
.
(03 April 2018)
Review Article
Association between CYP17A1 polymorphisms and response to abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review
AME Medical Journal
2018;
3:
50
.
(03 April 2018)